Vor Biopharma, Inc. (VOR)
14.48
+0.91
(+6.71%)
USD |
NASDAQ |
Mar 27, 16:00
14.44
-0.04
(-0.28%)
After-Hours: 20:00
Vor Biopharma EPS Diluted (Quarterly) : -121.63 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -812.68M |
| Total Expenses (Quarterly) | 812.68M |
| Enterprise Value | -68.34M |
| Earnings Yield | -2.64K% |
| Normalized Earnings Yield | -1062.30 |